Equity strategy:
Capture robust growth opportunities in the healthcare sector!
The global healthcare industry presents potentially profitable long-term investment opportunities in advancements focused on disease prevention, as in the case of the COVID-19 vaccine, as well as developments in Central Nervous System disorders (CNS), obesity or metabolic syndrome, and other rare cases.
We seek to outperform the market by projecting revenues from breakthrough medical advances.
Around the world, we see increases in health-related expenditures, particularly in countries with aging populations.
We invest in companies that are well-positioned to benefit from the growing demand for healthcare and those that are capable to improve the cost of healthcare via products and technology.
We capitalize on new market opportunities by investing in innovative companies that offer groundbreaking medical solutions for previously untreatable conditions.
Now more than ever, healthcare has become a top priority. Capture robust growth opportunities this industry could bring.
Healthcare is one of the most recession-resistant sectors as shown in its meaningful outperformance in previous downturns in the economy. Even today as markets are volatile, the healthcare sector is resilient against possible economic pitfalls because of medical advances, aging populations, and unmet medical needs – all of which support long-term growth!